---

September 06, 2023

Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion

Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion   Toronto, Ontario – September 6, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its…

Read full release →

August 21, 2023

Predictmedix AI Expands Diagnostic Reach in India with Innovative Diabetes Non-Invasive Screening

Toronto, Ontario – August 21, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced a recent technological milestone in its AI product suite – the ability to detect early…

Read full release →

August 10, 2023

Enhancing Healthcare Economics: Predictmedix AI’s Safe Entry Stations Revolutionize Safety and Efficiency

Toronto, Ontario – August 10 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its Safe Entry Stations as it relates to the healthcare vertical in…

Read full release →

August 02, 2023

Predictmedix AI Announces Milestone of Over 200,000 Individual Scans with AI-Powered Safe Entry Station

Toronto, Ontario – August 2, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is pleased to announce a significant milestone, having completed over 200,000 individual scans through its AI-powered Safe…

Read full release →

July 28, 2023

Predictmedix AI Provides Update on Commercialization of Safe Entry with the Indonesian Healthcare Sector

Toronto, Ontario, July 28, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA: 3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is pleased to…

Read full release →